These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Three-Dimensional Imaging Using Contrast-Enhanced and Three-Dimensional Ultrasound Techniques in the Ablative Zone Treated with a Multipolar Radiofrequency Ablation System for Hepatocellular Carcinoma. Tanaka T; Ikeda K; Sorin Y; Fukushima T; Kawamura Y; Kobayashi M; Kumada H Oncology; 2016; 90(5):255-60. PubMed ID: 26982013 [TBL] [Abstract][Full Text] [Related]
26. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography. Kim AY; Lee MW; Rhim H; Cha DI; Choi D; Kim YS; Lim HK; Cho SW Korean J Radiol; 2013; 14(5):754-63. PubMed ID: 24043968 [TBL] [Abstract][Full Text] [Related]
27. The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study. Chan AK; Hegarty C; Klass D; Yoshida E; Chung S; Liu DM; Ho SG; Harris AC Can Assoc Radiol J; 2015 May; 66(2):171-8. PubMed ID: 25637354 [TBL] [Abstract][Full Text] [Related]
28. Local ablation procedures in primary liver tumors: Levovist US versus spiral CTto evaluate therapeutic results. Vallone P; Gallipoli A; Izzo F; Fiore F; Delrio P Anticancer Res; 2003; 23(6D):5075-9. PubMed ID: 14981969 [TBL] [Abstract][Full Text] [Related]
29. Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound. Liu F; Yu X; Liang P; Cheng Z; Han Z; Dong B Int J Hyperthermia; 2011; 27(6):555-62. PubMed ID: 21797695 [TBL] [Abstract][Full Text] [Related]
30. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Minami T; Minami Y; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Inoue T; Hagiwara S; Ueshima K; Nishida N; Kudo M Oncology; 2014; 87 Suppl 1():55-62. PubMed ID: 25427734 [TBL] [Abstract][Full Text] [Related]
31. 3-D Contrast-Enhanced Ultrasound Fusion Imaging: A New Technique to Evaluate the Ablative Margin of Radiofrequency Ablation for Hepatocellular Carcinoma. Zhang X; Huang G; Ye J; Xu M; Cong L; He X; Huang T; Kuang M; Xie X Ultrasound Med Biol; 2019 Aug; 45(8):1933-1943. PubMed ID: 31109841 [TBL] [Abstract][Full Text] [Related]
32. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma. Luo W; Numata K; Morimoto M; Oshima T; Ueda M; Okada M; Takebayashi S; Zhou X; Tanaka K Eur J Radiol; 2010 Jul; 75(1):91-7. PubMed ID: 19361941 [TBL] [Abstract][Full Text] [Related]
33. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China. Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients. Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837 [TBL] [Abstract][Full Text] [Related]
35. Ultrasound fusion imaging of hepatocellular carcinoma: a review of current evidence. Minami Y; Kudo M Dig Dis; 2014; 32(6):690-5. PubMed ID: 25376285 [TBL] [Abstract][Full Text] [Related]
36. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673 [TBL] [Abstract][Full Text] [Related]
37. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma. Shin S; Lee JM; Kim KW; Joo I; Han JK; Choi BI; Klotz E AJR Am J Roentgenol; 2014 Jul; 203(1):70-7. PubMed ID: 24951197 [TBL] [Abstract][Full Text] [Related]
38. Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study. Bartoș A; Bartos D; Spârchez Z; Iancu I; Ciobanu L; Iancu C; Breazu C J Gastrointestin Liver Dis; 2019 Dec; 28(4):457-462. PubMed ID: 31826072 [TBL] [Abstract][Full Text] [Related]
39. Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations. Lee CH; Chen WT; Lin CC; Teng W; Lin SM; Chiu CT Kaohsiung J Med Sci; 2015 Aug; 31(8):413-9. PubMed ID: 26228280 [TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation. Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C; J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]